학술논문

Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
Document Type
Article
Source
In Annals of Oncology May 2019 30(5):788-795
Subject
Language
ISSN
0923-7534